64 related articles for article (PubMed ID: 35048639)
1. Why are Polish women diagnosed with invasive cervical cancer after negative cytology in the organized screening programme - a pilot reevaluation of negative Pap smears preceding diagnoses of interval cancers.
Komerska K; Macios A; Glińska P; Olszewski W; Didkowska J; Wojciechowska U; Kamiński MF; Nowakowski A
Pol J Pathol; 2021; 72(3):261-266. PubMed ID: 35048639
[TBL] [Abstract][Full Text] [Related]
2. Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme.
Macios A; Komerska K; Nowakowski A
Cancer Med; 2023 Jun; 12(12):13800-13810. PubMed ID: 37211978
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
4. Interlaboratory agreement in assessment of gynaecological cytology in Cervical Cancer Screening Programme in Poland - a pilot evaluation.
Zalewska-Otwinowska K; Macios A; Komerska K; Rekosz M; Nowakowski A
Pol J Pathol; 2021; 72(1):75-83. PubMed ID: 34060290
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
6. The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
Nowakowski A; Cybulski M; Śliwczyński A; Chil A; Teter Z; Seroczyński P; Arbyn M; Anttila A
BMC Cancer; 2015 Apr; 15():279. PubMed ID: 25879466
[TBL] [Abstract][Full Text] [Related]
7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
8. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
[TBL] [Abstract][Full Text] [Related]
10. Pap tests in the diagnosis of cervical cancer: Help or hinder?
Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
[TBL] [Abstract][Full Text] [Related]
11. Annual Papanicolaou screening for 5 years among human papillomavirus-negative women.
Petry KU; Rinnau F; Böhmer G; Hollwitz B; Luyten A; Buttmann N; Brünger M; Iftner T
BMC Cancer; 2013 Aug; 13():379. PubMed ID: 23937771
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
Tsiambas E; Riziotis C
Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
Koss LG; Lin E; Schreiber K; Elgert P; Mango L
Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
[TBL] [Abstract][Full Text] [Related]
14. Is a liquid-based cytology more sensitive than a conventional Pap smear?
Sigurdsson K
Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
[TBL] [Abstract][Full Text] [Related]
15. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
16. Repeated Positive Cervical HPV Testing and Absent or Minor Cytology Abnormality at Pap Smear. What is the Next Step?
Caeiro V; Nunes S; Esteves B; Moutinho-Fonseca J
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1907-1912. PubMed ID: 34181350
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
[TBL] [Abstract][Full Text] [Related]
18. Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting.
Holmström O; Linder N; Kaingu H; Mbuuko N; Mbete J; Kinyua F; Törnquist S; Muinde M; Krogerus L; Lundin M; Diwan V; Lundin J
JAMA Netw Open; 2021 Mar; 4(3):e211740. PubMed ID: 33729503
[TBL] [Abstract][Full Text] [Related]
19. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
20. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
